EPO Patents = 5

Trademarks = 5

Forward Citations = 7

Loading Chart...

9 inventors (with patents filed for the assignee):

Marie Dutreix (6 out of 14 patents)

Jian-Sheng Sun (3 out of 11 patents)

Maria Quanz (3 out of 5 patents)

4. Wael Jdey (2 out of 2 patents)

5. Corey Bloom (1 out of 30 patents)

6. Perrine Pivette (1 out of 2 patents)

7. Caroline Lemarchand (1 out of 7 patents)

8. Ian Yates (1 out of 3 patents)

9. Nathalie Berthault (1 out of 1 patent)

10. Maria Quanz (0 patent)

11. Maria Quanz-Schoeffel (0 patent)

7 patents: Sort by Forward Citations

1. 11266614 - Oral formulations of belinostat (2022-03-08),

2. 11162095 - Use of a combination of Dbait molecule and PARP inhibitors to treat cancer (2021-11-02),

3. 10821128 - Treatment of cancer by systemic administration of Dbait molecules (2020-11-03),

4. 10765758 - Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates (2020-09-08),

5. 10563197 - Use of a combination of Dbait molecule and PARP inhibitors to treat cancer (2020-02-18),

6. 10363317 - Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates (2019-07-30),

7. 9687557 - Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates (2017-06-27),

Onxeo is a clinical-stage biotechnology company developing innovative drugs for the treatment of cancer. The company's proprietary pipeline includes candidates targeting various types of cancer, with a focus on rare and aggressive forms. Onxeo's mission is to improve the lives of cancer patients through the development of novel and effective therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#418 in Paris

#2,183 in France

Paris, France

Onxeo